Saifu Pharmaceutical Funding: $42M Raised, Series C (2021)

Saifu Pharmaceutical is based in Beijing, China. It has raised $42M in total funding. Latest round: Series C. Backed by TH Capital, CICC Qide, Guangfa Qianhe.

Saifu Pharmaceutical funding overview

Saifu Pharmaceutical is based in Beijing, China. Saifu Pharmaceutical has raised $42M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in September 2021. The round record for Saifu Pharmaceutical runs through 2021; nothing later has been disclosed. Investors on record include TH Capital, CICC Qide, Guangfa Qianhe, Baotai Biotechnology. 4 distinct backers are named across the disclosed rounds.

Saifu Pharmaceutical at a glance

Total raised
$42M
Latest round
Series C
Latest round date
September 2021
Headquarters
Beijing, China
Notable investors
TH Capital, CICC Qide, Guangfa Qianhe, Baotai Biotechnology

Frequently asked about Saifu Pharmaceutical funding

How much has Saifu Pharmaceutical raised?
Saifu Pharmaceutical has raised $42M in total disclosed funding across the rounds on record.
Who has invested in Saifu Pharmaceutical?
TH Capital, CICC Qide, Guangfa Qianhe, Baotai Biotechnology are named among the investors backing Saifu Pharmaceutical.
What was the latest Saifu Pharmaceutical funding round?
The most recent disclosed round is a Series C, announced in September 2021.
Where is Saifu Pharmaceutical based?
Saifu Pharmaceutical is based in Beijing, China.
When did Saifu Pharmaceutical last raise?
The last disclosed Saifu Pharmaceutical round closed in September 2021 at Series C.

We update the Saifu Pharmaceutical record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Beijing and their backers are listed below.

Companies related to Saifu Pharmaceutical (19)

Browse related funding lists (5)

Company funding database · Investor directory · Founder database · Mega-rounds 2026